From 2022 to 2030, the global eubiotics market is expected to increase from USD 5.90 Billion to USD 10.10 Billion, with a CAGR of 7.43%.
FrequentlyAsked Questions
The major factors influencing the growth of the global eubiotics market include an increase in awareness about antibiotic alternatives, a surge in demand for better feed quality, nutrition & protein for animals, a rise in livestock population, and an increase in the consumption of meat among people across the globe.
According to the report, the global eubiotics market was worth around USD 5.90 Billion in 2021 and is projected to grow around USD 10.10 Billion by 2030, with a compounded annual growth rate (CAGR) of roughly 7.43% from 2022 to 2030.
The global eubiotics market is expected to be driven by the Europe region. The major reason for the growth of the market in this region is the increase in the production of livestock and the rise in meat consumption in countries like Germany, Italy, and France.
The major players in the global eubiotics market include DSM, Novozymes, Kemin Industries, Inc., Roquette Frères, FrieslandCampina, Neospark Drugs and Chemicals Private Limited, ASAHI GROUP HOLDINGS, Ltd., Lesaffre, MSPrebiotics Inc., ADM, Lallemand Inc., BEHN MEYER, NOVUS INTERNATIONAL, BENEO, Yara, Cargill, Incorporated, BASF SE, Chr. Hansen Holding A/S, and ADDCON GmbH among other global players.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed